Bladder Cancer Grants and Research Awards

Listed below are Bladder Cancer Advocacy Network (BCAN) research grants along with descriptions of each, deadlines, eligibility and more. For more information about these grants, please contact grants@bcan.org. Please visit our Grants and Research page for more information about each award.

Translational Clinical Trial AwardResearch Innovation AwardCareer Development AwardYoung Investigator Award (YIA) & Young Investigator Award for Patient-Centered Clinical Research (YIA-PCC)John Quale Travel Fellowship
Application DeadlineLOI: October 18, 2022
Invited Application: January 10, 2023
LOI: January 2023
Invited Application: April 2023
October 18, 2022February 2023March 2023
PurposeSupports early-phase patient-oriented translational research that transforms bladder cancerf care
Projects should address methods to reduce the burden of care or overtreatment for bladder cancer patients and have the potential to generate the evidence needed to advance clinical practice, guidelines, or standard of care
Supports exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding of bladder cancer
Projects must be high-risk, high-reward vs. incremental in nature
Supports junior investigators who have received their initial faculty appointment to establish an independent bladder cancer research program and career pathSupports the development of research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer
YIA-PCC: Supports patient-oriented clinical bladder cancer research
Supports early career investigators interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting. The travel fellowship is intended to defray travel-related costs for attending the meeting
Research FocusMust address methods to reduce the burden of care or overtreatment for bladder cancer patients throughout the continuum of patient care
Preference will be given to innovative clinical trials or translational research from ongoing or completed trials
Proposals that do not include a clinical trial must justify how the study will lead to a clinical trial as an immediate next step, or allow for translation of results into clinical practice
Must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and include innovative approaches and new ideas (e.g., novel theoretical concepts, methodologies, instrumentation, interventions, etc.)
Basic, translational, clinical, or epidemiologic research is acceptable
Must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma and must demonstrate the likelihood of translating new concepts into clinical practice
Translational, clinical, or epidemiological research is acceptable
Must be specific to bladder cancer and/or upper tract urothelial carcinoma 
YIA: Basic, translational, clinical, epidemiologic, bioengineering or any other field of research is acceptable
YIA-PCC: Must be patient-oriented clinical bladder cancer research (e.g., studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship)
The travel fellowship seeks to engage early career investigators with interests related to bladder cancer, including basic scientists, urologists, oncologists, and pathologists
EligibilityFull-time, independent investigators. Study teams must be composed of at least two investigators
Investigators with relevant expertise outside of bladder cancer seeking to apply approaches to bladder cancer are encouraged
Full-time, independent investigators
Investigators with relevant expertise outside of bladder cancer seeking to apply approaches to bladder cancer are encouraged
Applicant must be within the initial 7 years of their first full-time faculty appointment
Applicant may not hold the title of Associate or Full Professor
Applicant may not have previously secured major independent research funding (NIH R01 or equivalent)
Applicant must be within 6 years of completion of a professional degree or clinical training
Applicant may not hold the title of Associate Professor or higher
Applicants with a MD or PhD at the post-graduate, pre-faculty level who have not yet started a faculty appointment at the time of submission
Prior JQTF winners are not eligible
Required DegreeMedical and/or doctoral degree in the biomedical sciences or a field applicable to health science research
Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research
Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research
YIA: Medical and/or doctoral degree in the biomedical sciences or a field applicable to health science research.
PCC: MD, DO, PhD, MD-PhD, MPH, MS, DNP, DScPAS or equivalent.
MD in the final year of residency or a fellowship program; PhD postdoctoral fellows
Award PeriodUp to 3 years2 years3 years1 yearBladder Cancer Think Tank Meeting
2022: August 3-5th
Total Funding
Indirect Costs
Studies proposing clinical trials: Up to $3 million 
All other studies: Up to $1 million
A maximum of 10% of total costs may be used for indirect costs
$300,000 ($150,000 per year)
A maximum of 10% of total direct costs may be used for indirect costs
$250,000 over 3 years
Up to 7% per year may be applied to indirect costs
$50,000
Not allowable
$2,000
N/A
Mentored Award?NoNoNoApplicant must have a mentor within or approved by the sponsoring institutionN/A